Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 2
1996 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
The potential of protein kinase C as a target for anticancer treatment.
Basu A. Basu A. Pharmacol Ther. 1993 Sep;59(3):257-80. doi: 10.1016/0163-7258(93)90070-t. Pharmacol Ther. 1993. PMID: 8309991 Review.
Oncogenic transformation alters cisplatin-induced apoptosis in rat embryo fibroblasts.
Basu A, Cline JS. Basu A, et al. Int J Cancer. 1995 Nov 15;63(4):597-603. doi: 10.1002/ijc.2910630422. Int J Cancer. 1995. PMID: 7591272
Comparison of protein kinase C activity and isoform expression in cisplatin-sensitive and -resistant ovarian carcinoma cells.
Basu A, Weixel KM. Basu A, et al. Int J Cancer. 1995 Aug 9;62(4):457-60. doi: 10.1002/ijc.2910620416. Int J Cancer. 1995. PMID: 7635571
Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
Basu A, Weixel K, Saijo N. Basu A, et al. Cell Growth Differ. 1996 Nov;7(11):1507-12. Cell Growth Differ. 1996. PMID: 8930400 Free article.
Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
Basu A, Lazo JS. Basu A, et al. Cancer Res. 1992 Jun 1;52(11):3119-24. Cancer Res. 1992. PMID: 1591725 Free article.
Comparison of effects of growth factors and protein kinase C activators on cellular sensitivity to cis-diamminedichloroplatinum(II).
Basu A, Evans RW. Basu A, et al. Int J Cancer. 1994 Aug 15;58(4):587-91. doi: 10.1002/ijc.2910580423. Int J Cancer. 1994. PMID: 8056456
Feedback